Uric acid and endothelial dysfunction in essential hypertension

Journal of the American Society of Nephrology

Volumn 17, Issue 5, 2006, Pages 1466-1471

  Zoccali, Carmine ^a   Maio, Raffaele ^b   Mallamaci, Francesca ^a   Sesti, Giorgio ^b   Perticone, Francesco ^b,c  

^a CNR Consiglio Nazionale delle Ricerche   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c Policlinico Mater Domini   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; C REACTIVE PROTEIN; CREATININE; URIC ACID;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC INFLAMMATION; CREATININE BLOOD LEVEL; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; FEMALE; FOREARM BLOOD FLOW; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INSULIN RESISTANCE; KIDNEY DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MODEL; MULTIPLE REGRESSION; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL MODEL; URIC ACID BLOOD LEVEL; VASODILATATION;

EID: 33646376660     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005090949     Document Type: Article

References (34)

1. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, Davos CH, Cicoira M, Shamim W, Kemp M, Segal R, Osterziel KJ, Leyva F, Hetzer R, Ponikowski P, Coats AJ: Uric acid and survival in chronic heart failure: Validation and application in metabolic, functional, and hemodynamic staging. Circulation 107: 1991-1997, 2003
2. Liese AD, Hense HW, Lowel H, Doring A, Tietze M, Keil U: Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology 10: 391-397, 1999
3. Lehto S, Niskanen L, Ronnemaa T, Laakso M: Serum uric acid is a strong predictor of stroke in patients with noninsulin-dependent diabetes mellitus. Stroke 29: 635-639, 1998
4. Breckenridge A: Hypertension and hyperuricaemia. Lancet 1: 15-18, 1966
5. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M: Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41: 1183-1190, 2003
6. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ: Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38: 1101-1106, 2001
7. Sanchez-Lozada LG, Tapia E, Santamaria J, Avila-Casado C, Soto V, Nepomuceno T, Rodriguez-Iturbe B, Johnson RJ, Herrera-Acosta J: Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int 67: 237-247, 2005
8. Johnson RJ, Feig DI, Herrera-Acosta J, Kang DH: Resurrection of uric acid as a causal risk factor in essential hypertension. Hypertension 45: 18-20, 2005
9. Maxwell AJ, Bruinsma KA: Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease. J Am Coll Cardiol 38: 1850-1858, 2001
10. Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M, Rosano GM: Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 94: 932-935, 2004
11. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323: 22-27, 1990
12. Sundstrom J, Sullivan L, D'Agostino RB, Levy D, Kannel WB, Vasan RS: Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 45: 28-33, 2005
13. Brunner H, Cockcroft JR, Deanfield J, Donald A, Ferrannini E, Halcox J, Kiowski W, Luscher TF, Mancia G, Natali A, Oliver JJ, Pessina AC, Rizzoni D, Rossi GP, Salvetti A, Spieker LE, Taddei S, Webb DJ: Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 23: 233-246, 2005
14. Perticone F, Maio R, Tripepi G, Zoccali C: Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation 110: 821-825, 2004
15. Levey AS, Bosch JP, Breyer Lewis J, Greene T, Rogers N, Roth D; for the Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461-470, 1999
16. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P, Schillaci G: Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104: 191-196, 2001
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner R: Homeostatic model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985
18. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ: Hyperuricemia induces endothelial dysfunction. Kidney Int 67: 1739-1742, 2005
19. Kang DH, Park SK, Lee IK, Johnson RJ: Uric acid-induced C-reactive protein expression: Implication on cell proliferation and nitric oxide production of human vascular cell. J Am Soc Nephrol 16: 3553-3562, 2005
20. Farquharson CA, Butler R, Hill A, Belch JJ, Struthers AD: Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 106: 221-226, 2002
21. Butler R, Morris AD, Belch JJ, Hill A, Struthers AD: Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35: 746-751, 2000
22. Cardillo C, Kilcoyne CM, Cannon RO III, Quyyumi AA, Panza JA: Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension 30: 57-63, 1997
23. Li JM, Shah AM: Endothelial cell superoxide generation: Regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Megr Comp Physiol 287: R1014-R1030, 2004
24. Nakagawa T, Tuttle KR, Short RA, Johnson RJ: Hypothesis: Fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol 1: 80-86, 2005
25. Kanabrocki EL, Third JL, Ryan MD, Nemchausky BA, Shirazi P, Scheving LE, McCormick JB, Hermida RC, Bremner WF, Hoppensteadt DA, Fareed J, Olwin JH: Circadian relationship of serum uric acid and nitric oxide. JAMA 283: 2240-2241, 2000
26. Waring WS, Adwani SH, Breukels O, Webb DJ, Maxwell SR: Hyperuricaemia does not impair cardiovascular function in healthy adults. Heart 90: 155-159, 2004
27. Hellsten Y, Tullson PC, Richter EA, Bangsbo J: Oxidation of urate in human skeletal muscle during exercise. Free Radic Biol Med 22: 169-174, 1997
28. Becker BF: Towards the physiological function of uric acid. Free Radic Biol Med 14: 615-631, 1993
29. Viazzi F, Parodi D, Leoncini G, Parodi A, Falqui V, Ratto E, Vettoretti S, Bezante GP, Del Sette M, Deferrari G, Pontremoli R: Serum uric acid and target organ damage in primary hypertension. Hypertension 45: 991-996, 2005
30. Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M: Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol 25: 1038-1044, 2005
31. Lind L, Sarabi M, Millgard J: Methodological aspects of the evaluation of endothelium-dependent vasodilatation in the human forearm. Clin Physiol 18: 81-87, 1998
32. Johnson RJ, Rodriguez-Iturbe B, Kang DH, Feig DI, Herrera-Acosta J: A unifying pathway for essential hypertension. Am J Hypertens 18: 431-440, 2005
33. Leyva F, Anker SD, Godsland IF, Teixeira M, Hellewell PG, Kox WJ, Poole-Wilson PA, Coats AJ: Uric acid in chronic heart failure: A marker of chronic inflammation. Eur Heart J 19: 1814-1822, 1998
34. Zoccali C, Maio R, Tripepi G, Mallamaci F, Perticone F: Inflammation as a mediator of the link between mild to moderate renal insufficiency and endothelial dysfunction in essential hypertension. J Am Soc Nephrol 17[Suppl 2]: S64-S68, 2006